Literature DB >> 7919338

Molecular analysis of Polish patients with factor VII deficiency.

A A Arbini1, D Bodkin, S Lopaciuk, K A Bauer.   

Abstract

We analyzed the mutations in patients from 10 Polish kindreds with a bleeding diathesis due to factor VII deficiency. Patients from eight families had plasma levels of factor VII coagulant activity (VII:C) and factor VII antigen (VII:Ag) that were less than 4% of normal. The coding sequence of the factor VII gene was amplified from genomic DNA by polymerase chain reaction (PCR). Sequencing demonstrated a C to T transition at position 10798 resulting in Ala294Val, a G to A transition at 10976 resulting in Arg353Gln, and a single bp deletion at 11125 to 11128 causing a frameshift mutation in the triplet encoding amino acid 404. Homozygosity for the three sequence alterations was confirmed with the restriction enzymes AvaII and MspI and allele specific PCR, respectively. A homozygous patient from a ninth family with levels of VII:C and VII:Ag of 4% and 17%, respectively, had Ala294Val and the frameshift mutation, but not Arg353Gln. Investigation of a homozygous patient from a tenth kindred with VII:C and VII:Ag of 11% and 47%, respectively, demonstrated Ala294Val and Arg353Gln, but not the frameshift mutation. Based on the above data, we conclude that the frameshift mutation in the codon for amino acid 404 is associated with marked reductions in VII:C, Arg353Gln can decrease plasma levels of factor VII in the presence of other mutations in the factor VII gene, and Ala294Val results in a dysfunctional factor VII molecule.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919338

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

2.  A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.

Authors:  Raffaella Toso; Mirko Pinotti; Katherine A High; Eleanor S Pollak; Francesco Bernardi
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

3.  Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects?

Authors:  Liliya Alexandrovna Belozerceva; Elena Nikolaevna Voronina; Natalia Viktorovna Kokh; Galina Alexandrovna Tsvetovskay; Andrei Pavlovich Momot; Galina Israilevna Lifshits; Maxim Leonidovich Filipenko; Andrei Ivanovich Shevela; Valentin Viktorovich Vlasov
Journal:  EPMA J       Date:  2012-09-27       Impact factor: 6.543

4.  Association of warfarin dose with genes involved in its action and metabolism.

Authors:  Mia Wadelius; Leslie Y Chen; Niclas Eriksson; Suzannah Bumpstead; Jilur Ghori; Claes Wadelius; David Bentley; Ralph McGinnis; Panos Deloukas
Journal:  Hum Genet       Date:  2006-10-18       Impact factor: 4.132

5.  Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.

Authors:  Wen-Bin He; Yue-Qiu Tan; Xiao Hu; Wen Li; Bo Xiong; Ke-Li Luo; Fei Gong; Guang-Xiu Lu; Ge Lin; Juan Du
Journal:  BMC Med Genet       Date:  2018-01-24       Impact factor: 2.103

6.  Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.

Authors:  Réka Gindele; Adrienne Kerényi; Judit Kállai; György Pfliegler; Ágota Schlammadinger; István Szegedi; Tamás Major; Zsuzsanna Szabó; Zsuzsa Bagoly; Csongor Kiss; János Kappelmayer; Zsuzsanna Bereczky
Journal:  Life (Basel)       Date:  2021-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.